Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX)
A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
pchop123
(76.60)
Submitted: 5/20/2013 12:19:41 PM :
Start Price:
$4.24
PGNX Score:
+4.45
smart short
Recs
scrubs62074
(81.49)
Submitted: 2/20/2013 10:59:26 AM :
Start Price:
$2.90
PGNX Score:
+30.16
Bullish MACD crossover on 02/20/13
Recs
MicroMagic
(60.05)
Submitted: 9/25/2012 11:51:15 PM :
Start Price:
$3.32
PGNX Score:
-5.75
This company has a bright future with it's injectable drug to cure the terrible affliction many pain killer addicts have with constipation.
Since there is no known cure for constipation anywhere out there.
Recs
SamsaricSufferer
(< 20)
Submitted: 7/4/2012 8:14:51 PM :
Start Price:
$10.39
PGNX Score:
-83.44
PDUFA coming up.
Recs
GameEmag
(< 20)
Submitted: 1/29/2012 5:26:11 PM :
Start Price:
$9.54
PGNX Score:
+85.96
The recent jump in share price (Dec. '11-Current) has no basis in reality and seems fueled only by investors given to hoping for the best and low volume days allowing an easy path for pumping prices temporarily. To borrow words from so many market pundits it is the picture of "irrational exuberance."
Recs
1stMartian
(< 20)
Submitted: 12/6/2011 11:26:56 PM :
Start Price:
$7.41
PGNX Score:
+78.50
Piggy back off Z's analysis.
Recs
targetphil3
(< 20)
Submitted: 10/1/2010 6:10:41 PM :
Start Price:
$5.05
PGNX Score:
-66.55
CEO buying shares on regular basis
Recs
mmacioci
(33.08)
Submitted: 9/5/2010 7:10:30 PM :
Start Price:
$4.38
PGNX Score:
-59.56
John Paul Pick ask Ray
Recs
nhanhsong
(< 20)
Submitted: 6/23/2010 6:09:13 AM :
Start Price:
$5.62
PGNX Score:
+81.07
If PGNX can't find a new partner for RELISTOR this year, it will face some difficulty with finance.
Recs
roalercoaster
(41.93)
Submitted: 3/29/2010 10:25:11 PM :
Start Price:
$5.22
PGNX Score:
-65.30
Upcoming Catalyst
Recs
BeaterOfFools
(48.77)
Submitted: 3/13/2010 7:41:36 PM :
Start Price:
$5.28
PGNX Score:
-68.93
Red Raider is Lord
Recs
FoolBeater
(< 20)
Submitted: 3/13/2010 7:24:08 PM :
Start Price:
$5.28
PGNX Score:
-68.93
Lord knows
Recs
tdmitchell08
(< 20)
Submitted: 2/9/2010 1:08:29 AM :
Start Price:
$4.52
PGNX Score:
-67.05
I need help. I think this company will do well based on they look like they are at a low point, but will bounce back. If someone would like to let me know why I am right or wrong I would apprecaite it.
Recs
Contralogic
(26.32)
Submitted: 1/23/2010 10:11:50 AM :
Start Price:
$4.60
PGNX Score:
-64.22
Go Bio!
Recs
biofest
(51.30)
Submitted: 12/6/2009 3:19:13 PM :
Start Price:
$4.14
PGNX Score:
-53.43
Speculative but possible cancer effect from pain drug.
Recs
Baski101
(< 20)
Submitted: 11/17/2009 9:17:29 AM :
Start Price:
$4.17
PGNX Score:
-54.12
Its basically cash rich, has a few good products waiting to be launched once a partner is found for marketing, and its current stock price is an all time low, which can't get any worse than this.
Recs
Recs
HERMANBERNSTEIN
(< 20)
Submitted: 5/1/2009 8:42:25 AM :
Start Price:
$5.48
PGNX Score:
-120.21
EXCELLENT PIPELINE, NO DEBT, GOOD MANAGEMENT
Recs
OOooMercuryooOO
(< 20)
Submitted: 8/15/2008 7:10:20 PM :
Start Price:
$13.37
PGNX Score:
-102.70
Down on no news - owned this through FDA and EMEA approvals but then sold out - back now since it's at the same levels again but closer to profitability and/or buyout (Wyeth?)
Recs
timmymac61
(39.57)
Submitted: 6/5/2008 8:27:29 AM :
Start Price:
$16.30
PGNX Score:
-100.81
has found a firm base will retest mid to high twentys by end of fall
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 33 : 1 2 Next »